Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03079882 · ClinicalTrials.gov registry record
VisR Ultrasound for Noninvasively Monitoring Renal Allograft Health
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 65
- Enrollment target
NCT03079882: Completed study, sponsored by University of North Carolina, Chapel Hill.
NCT03079882 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 65 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03079882 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 65 participants
- Enrollment target
Study Summary
Ten percent of American adults, more than 20 million people, have chronic kidney disease, which in the advanced state of end stage renal disease is most desirably and cost-effectively treated by kidney transplantation. However, 20-30% of transplanted kidneys fail in living recipients by 10 years, owing largely to insufficient monitoring methods. The goal of the proposed research is to improve noninvasive kidney transplant monitoring using a new ultrasound-based imaging method called Viscoelastic Response (VisR) ultrasound.
Primary Outcome
AUC for VisR to detect positive biopsy finding (indiscriminate of type)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2016-06-16 |
| Est. Completion | 2021-02-28 |
What the finished NCT03079882 record still lists
NCT03079882 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 65 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03079882 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03079882 about?
NCT03079882 is a clinical study titled "VisR Ultrasound for Noninvasively Monitoring Renal Allograft Health". Ten percent of American adults, more than 20 million people, have chronic kidney disease, which in the advanced state of end stage renal disease is most desirably and cost-effectively treated by kidney transplantation. However, 20-30% of transplanted kidneys fail in living recipients by 10 years, ow...
What is the current status of trial NCT03079882?
This trial is currently completed. The enrollment target is 65 participants. The study started on 2016-06-16. Estimated completion is 2021-02-28.
Who is sponsoring clinical trial NCT03079882?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03366116 · 65 participants · Phase 1
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
- NCT03603730 · 65 participants · NA
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
- NCT03796559 · 65 participants · NA
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes
- NCT03993106 · 65 participants · Phase 2
A Study of sEphB4-HSA in Kaposi Sarcoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI